DANIELLE DUBIEL: Open Payments
NPI 1801265319 · SHENANDOAH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,028 in 61 payments from 17 companies in 2025. Trend: 2023 $2,530 · 2024 $2,680 · 2025 $2,028
Food & beverage: $1,945Education: $83
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $267 |
| PFIZER INC. | 5 | $260 |
| Arcutis Biotherapeutics, Inc. | 3 | $256 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $213 |
| Galderma Laboratories, L.P. | 14 | $213 |
| ABBVIE INC. | 7 | $188 |
| Novartis Pharmaceuticals Corporation | 6 | $173 |
| Lilly USA, LLC | 1 | $105 |
| LEO Pharma Inc. | 3 | $74 |
| UCB, Inc. | 2 | $56 |
Products named: TREMFYA, Zoryve, NEMLUVIO, CIBINQO, SKYRIZI, ILUMYA, EBGLYSS, LITFULO.
Industry payments across TX — which companies pay providers there.
